4//SEC Filing
AMAG PHARMACEUTICALS INC. 4
Accession 0001179110-17-006983
CIK 0000792977operating
Filed
May 9, 8:00 PM ET
Accepted
May 10, 4:42 PM ET
Size
5.0 KB
Accession
0001179110-17-006983
Insider Transaction Report
Form 4
Grund Nicholas
Chief Commercial Officer
Transactions
- Tax Payment
Common Stock
2017-05-08$18.55/sh−3,483$64,610→ 48,517 total
Footnotes (1)
- [F1]Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 10,665 restricted stock units ("RSUs") on January 4, 2017. Due to the black-out policies implemented by AMAG Pharmaceuticals, Inc. (the "Issuer"), the shares of the Issuer's Common Stock underlying such vested RSUs were not delivered to the reporting person until May 8, 2017, at which time 3,483 shares were withheld to satisfy the reporting person's applicable tax obligations.
Documents
Issuer
AMAG PHARMACEUTICALS INC.
CIK 0000792977
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000792977
Filing Metadata
- Form type
- 4
- Filed
- May 9, 8:00 PM ET
- Accepted
- May 10, 4:42 PM ET
- Size
- 5.0 KB